-

Claritas Rx Appoints New CFO and Head of Marketing

Leadership Transformation Designed to Continue Growth and Scale

original Kevin Donalds joins Claritas Rx as Chief Financial Officer.

Kevin Donalds joins Claritas Rx as Chief Financial Officer.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced new leadership appointments designed to continue growth and scale. The company has welcomed Kevin Donalds as Chief Financial Officer (CFO) and Elizabeth Marshall as Head of Marketing. Both will report directly to Michael Fitzgibbons, Claritas Rx’s CEO.

“I’m delighted to welcome both Kevin and Liz to our Claritas Rx Executive Team,” said Michael Fitzgibbons.

Share

Mr. Donalds has been the CFO at several highly successful B2B SaaS companies including Granular, Tutor.com and Popkin Software. He also held Finance leadership roles at Priceline and META Group. He started his career in public accounting at Deloitte. Kevin holds a BS in accounting from the University of Rhode Island and a CPA.

Ms. Marshall comes to Claritas Rx with significant Marketing and Communications experience at high-growth companies. She held Marketing leadership positions at Trinity Life Sciences, IDEMIA and Decision Resource Group (DRG). She holds a BS from the Newhouse School of Public Communications at Syracuse University and an MBA from Boston University.

“I’m delighted to welcome both Kevin and Liz to our Claritas Rx Executive Team,” said Michael Fitzgibbons. “As we continue to scale, their background and expertise will help us not only manage long-term growth initiatives that are beneficial to our clients, but also the internal change management that is critical to a fast-growing company.”

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx is a technology company focused on managing real world data focused on specialty biopharmaceutical distribution channels in oncology and rare/orphan diseases. Since 2011, the company has illuminated brand performance and the patient journey for dozens of therapies. Claritas Rx creates actionable business intelligence that helps manufacturers more effectively go to market and enhance the patient experience. For more information, visit www.claritasrx.com.

Contacts

Media Contact: Emily Brennan, EBrennan@ClaritasRx.com

Industry:

Claritas Rx

Release Versions
English

Contacts

Media Contact: Emily Brennan, EBrennan@ClaritasRx.com

More News From Claritas Rx

Claritas Rx Appoints Biopharma Commercial Leader Jonathan Witt to Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the appointment of Jonathan Witt to its Board of Directors. Mr. Witt is an accomplished senior executive with more than 25 years of experience in U.S. and global biopharmaceutical roles. He has a proven record of evaluating market opportunities across diverse therapeutic areas, setting development, commercialization, and corporate strategy, building and scaling enterprise capabilities, and tr...

Relay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease Programs

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, and Relay Network, a leader in HIPAA-Compliant, mobile-first patient engagement, today announced a strategic partnership to help life sciences companies close critical gaps in patient access, support, and adherence. The collaboration combines Claritas Rx’s specialty pharmacy, hub, and program-level data with Relay Network’s interactive, feed-based communication channel to deliver personalized, 1:1 mobile exp...

Everest Group Finds Patients in Rare and Specialty Markets Are Getting More Touches and Less Help

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the release of a new Everest Group white paper: From Fragmented to Orchestrated: Omnichannel Engagement in Patient Services. The white paper addresses a persistent challenge in life sciences: despite significant investment in omnichannel patient engagement, most patient support programs still deliver fragmented, inconsistent experiences. Patients receive repeated outreach, conflicting guidance...
Back to Newsroom